Key Breast Journal Articles - Adjuvant Chemo
Published: Fri Apr 29, 2011 Updated:Thu Sep 29, 2011
-
Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer
Kelly CM. et al; March 20, 2012; JCO; 30(9); 901-3.
-
Adjuvant capecitabine, docetaxel, cyclophosphamid, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H. et al; January 1, 2012; JCO; 30(1); 11-8.
-
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analysis of long-term outcome amoung 100,000 women in 123 randomised trials.
Peto R. et al; February 4, 2012; Lancet; 379(9814); 432-44
-
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Baselga J. et al; February 18, 2012; Lancet; 379(9816); 633-40
-
Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment Crossover
Jin H. et al; October 31, 2011; JCO; doi: 10.1200/JCO.2010.34.4010
-
Breast-Cancer Adjuvant Therapy with Zoledronic Acid
Coleman RE. et al; October 13, 2011; NEJM; 365; 1396-1405
-
Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2–Normal, Node-Positive Breast Cancer: BCIRG-005 Trial
Eiermann W. et al; September 12, 2011; JCO; doi: 10.1200/JCO.2010.28.5437
-
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open label, phase III, randomised controlled trial
Ellis P. et al; May 16, 2009; Lancet; 373(9676); 1681-92
-
Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Rastogi P. et al; February 10, 2008; JCO; 26(5); 778-785
-
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
Goldhirsch A. et al; October 25, 2007; Annals of Oncology; 18(7); 1133-44
-
Her2 and Response to Paclitaxel in Node Positive Breast Cancer
Hayes DF. et al; October 11, 2007; NEJM; 357(15); 1496-506
-
Current Concepts: Local Therapy and Survival in Breast Cancer
Punglia RS. et al; June 7, 2007; NEJM; 356(23); 2399-405
-
Meta-analysis of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview
Clarke M. et al; September 2006; Annals of Oncology; 17(S10)
-
Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial
Roché H. et al; December 20, 2006; JCO; 24(36); 5664-71
-
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
Paik S. et al; August 10, 2006; JCO; 24(23); 3726-34
-
HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
Pritchard KI. et al; May 18, 2006; NEJM; 354(20); 2103-11
-
Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer
Berry DA. et al; Apr 12, 2006; JAMA 295(14); 1658-67
-
Adjuvant Therapy for Breast Cancer in Older Women
Hurria A. et al; ASCO 2006 Educational Book
-
Adjuvant Chemotherapy for Patients With Estrogen Receptor--Positive Breast Cancer
Burstein HJ. et al; ASCO 2006 Educational Book
-
Selection of Adjuvant Chemotherapy for Treatment of Node-positive Breast Cancer
Trudeau M. et al; November 2005; Lancet; 6(11); 886-98
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) et al; May 14-20, 2005; Lancet; 365(9472); 1687-717
-
Adjuvant Chemotherapy in Older and Younger Women With Lymph Node–Positive Breast Cancer
Muss HB. et al; March 2, 2005; JAMA; 293(9); 1073-81
-
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik S. et al; December 30, 2004; NEJM; 351(27); 2817-26
-
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI
Pagani O. et al; Apr 1998; Eur J Cancer; 34(5); 632-40
-
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18
Fishe B. et al; July 1, 1997; JCO; 15(7); 2483-2493
-
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22
Fisher B. et al; May 1, 1997; JCO; 15(5); 1858-69
-
Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up
Bonadonna G. et al; April 6, 1995; NEJM; 332; 901-906
